Atlas Trials

Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)

Clinical trial NCT00481962 · COMPLETED

Trial details

NCT number
NCT00481962
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Peritonitis
Start date
2006-02-01
Primary completion
2008-12-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.